Document is current

Any future updates will be listed below

Efficacy of sorafenib in BRAF-mutated non-small-cell lung cancer (NSCLC) and no response in synchronous BRAF wild type-hepatocellular carcinoma: a case report

Crossref DOI link: https://doi.org/10.1186/s12885-016-2463-2

Published Online: 2016-07-07

Published Print: 2016-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark